Nerve growth factor: an update on the science and therapy

Area of Science:

• Pain management research
• Neuroscience
• Pharmacology

Background:

• Nerve growth factor (NGF) plays a crucial role in nociceptive pain signaling.
• Targeting NGF offers a potential strategy for novel analgesic medications.
• Neurogenic inflammation is a key process in pain development.

Purpose of the Study:

• To review the principles of neurogenic inflammation.
• To evaluate the efficacy and safety of anti-NGF regimens in preclinical and clinical studies.
• To assess anti-NGF treatments for back pain and osteoarthritis (OA).

Main Methods:

• Systematic literature search using Google Scholar and PubMed.
• Inclusion of articles and abstracts on NGF and anti-NGF clinical trials.
• Review of efficacy findings and adverse events (AEs) from identified studies.

Main Results:

• Five full articles and eight abstract reports on anti-NGF agents for back pain and OA were identified.
• Anti-NGF agents, alone or with NSAIDs, demonstrated greater efficacy than NSAIDs alone for knee and hip pain.
• Adverse events, including rapidly progressive OA and joint replacement, were more frequent with combined anti-NGF and NSAID therapy.

Conclusions:

• Anti-NGF agents represent a promising therapeutic class for pain management.
• Combination therapy with NSAIDs enhances efficacy but increases the risk of serious adverse events.
• Neurologic symptoms associated with anti-NGF treatment require further investigation.